116 related articles for article (PubMed ID: 38149540)
1. Anergy to purified protein derivative and chronic energy deficiency in sputum-positive pulmonary tuberculosis: Dynamic assessment at baseline and treatment completion.
Alexander V; Sindhu KN; Ralph R; Paul JS; Manimegalai B; Zachariah A
Int J Mycobacteriol; 2023; 12(4):436-442. PubMed ID: 38149540
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.
Delgado JC; Tsai EY; Thim S; Baena A; Boussiotis VA; Reynes JM; Sath S; Grosjean P; Yunis EJ; Goldfeld AE
Proc Natl Acad Sci U S A; 2002 May; 99(11):7576-81. PubMed ID: 12032325
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis screening in dialysis patients--is the tuberculin test effective?
Poduval RD; Hammes MD
Clin Nephrol; 2003 Jun; 59(6):436-40. PubMed ID: 12834175
[TBL] [Abstract][Full Text] [Related]
4. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
[TBL] [Abstract][Full Text] [Related]
5. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
[TBL] [Abstract][Full Text] [Related]
6. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
[TBL] [Abstract][Full Text] [Related]
7. Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area.
Fang HC; Chou KJ; Chen CL; Lee PT; Chiou YH; Hung SY; Chung HM
Nephron; 2002 Aug; 91(4):682-7. PubMed ID: 12138273
[TBL] [Abstract][Full Text] [Related]
8. Th2 biased immune response in cases with active Mycobacterium tuberculosis infection and tuberculin anergy.
Balikó Z; Szereday L; Szekeres-Bartho J
FEMS Immunol Med Microbiol; 1998 Nov; 22(3):199-204. PubMed ID: 9848680
[TBL] [Abstract][Full Text] [Related]
9. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
[TBL] [Abstract][Full Text] [Related]
11. Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel.
García-García ML; Valdespino-Gómez JL; García-Sancho C; Mayar-Maya ME; Palacios-Martínez M; Balandrano-Campos S; Escobar-Gutiérrez A; Peruga A; Weissenbacher M; Daniels E
Int J Epidemiol; 2000 Apr; 29(2):369-75. PubMed ID: 10817138
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).
Anastos K; Kalish LA; Palacio H; Benson CA; Delapenha R; Chirgwin K; Stonis L; Telzak EE
J Acquir Immune Defic Syndr; 1999 Jun; 21(2):141-7. PubMed ID: 10360806
[TBL] [Abstract][Full Text] [Related]
13. High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy.
Mow WS; Abreu-Martin MT; Papadakis KA; Pitchon HE; Targan SR; Vasiliauskas EA
Clin Gastroenterol Hepatol; 2004 Apr; 2(4):309-13. PubMed ID: 15067625
[TBL] [Abstract][Full Text] [Related]
14. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis.
MMWR Recomm Rep; 1991 Apr; 40(RR-5):27-32. PubMed ID: 2034206
[TBL] [Abstract][Full Text] [Related]
15. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection.
Villarino ME; Geiter LJ; Schulte JM; Castro KG
AIDS; 1994 Apr; 8(4):477-81. PubMed ID: 8011250
[TBL] [Abstract][Full Text] [Related]
16. Tuberculin screening of trauma admissions at a university hospital. A preventive strategy.
Taneja R; Merritt S; Vanek S; Passannante M; Livingston DH
Arch Surg; 1995 Nov; 130(11):1223-6; discussion 1226-7. PubMed ID: 7487466
[TBL] [Abstract][Full Text] [Related]
17. Risk for developing tuberculosis among anergic patients infected with HIV.
Moreno S; Baraia-Etxaburu J; Bouza E; Parras F; Pérez-Tascón M; Miralles P; Vicente T; Alberdi JC; Cosín J; López-Gay D
Ann Intern Med; 1993 Aug; 119(3):194-8. PubMed ID: 8100693
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of tuberculin reactivity among healthcare workers from a Mexican hospital.
Molina-Gamboa J; Fivera-Morales I; Ponce-de-León-Rosales S
Infect Control Hosp Epidemiol; 1994 May; 15(5):319-20. PubMed ID: 8077644
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
Schwander SK; Dietrich M; Mugyenyi P; Kityo C; Okwera A; Johnson J; Nsubuga P; Ruesch-Gerdes S; Whalen C
East Afr Med J; 1997 Sep; 74(9):543-8. PubMed ID: 9487427
[TBL] [Abstract][Full Text] [Related]
20. Selection of skin test antigens to evaluate PPD anergy.
Wright PW; Crutcher JE; Holiday DB
J Fam Pract; 1995 Jul; 41(1):59-64. PubMed ID: 7798066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
